These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37022291)

  • 1. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices.
    Gaffney S; Kelly DM; Rameli PM; Kelleher E; Martin-Loeches I
    APMIS; 2023 Nov; 131(11):654-667. PubMed ID: 37022291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
    Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
    Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
    Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP
    J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of influenza-associated pulmonary aspergillosis among critically ill patients: a systematic review and meta-analysis.
    Chong WH; Saha BK; Tan CK
    J Hosp Infect; 2022 Feb; 120():98-109. PubMed ID: 34843812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive pulmonary aspergillosis associated with viral pneumonitis.
    Dewi IM; Janssen NA; Rosati D; Bruno M; Netea MG; Brüggemann RJ; Verweij PE; van de Veerdonk FL
    Curr Opin Microbiol; 2021 Aug; 62():21-27. PubMed ID: 34034082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.
    Vanderbeke L; Spriet I; Breynaert C; Rijnders BJA; Verweij PE; Wauters J
    Curr Opin Infect Dis; 2018 Dec; 31(6):471-480. PubMed ID: 30299367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
    Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
    Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
    Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
    Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
    Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
    Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillosis in Critically Ill Patients with and Without COVID-19 in a Tertiary Hospital in Southern Brazil.
    Trápaga MR; Poester VR; Basso RP; Blan BDS; Munhoz LS; Pasqualotto AC; Werner TDF; Figurelli ML; Stevens DA; von Groll A; Xavier MO
    Mycopathologia; 2024 Jun; 189(3):48. PubMed ID: 38847987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
    Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches.
    Jenks JD; Nam HH; Hoenigl M
    Mycoses; 2021 Sep; 64(9):1002-1014. PubMed ID: 33760284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
    Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
    Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
    Chong WH; Neu KP
    J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort.
    Versyck M; Zarrougui W; Lambiotte F; Elbeki N; Saint-Leger P
    J Mycol Med; 2021 Jun; 31(2):101122. PubMed ID: 33621792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
    Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
    J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Lu LY; Lee HM; Burke A; Li Bassi G; Torres A; Fraser JF; Fanning JP
    Chest; 2024 Mar; 165(3):540-558. PubMed ID: 37742914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.
    Huang L; He H; Jin J; Zhan Q
    BMC Infect Dis; 2017 Mar; 17(1):209. PubMed ID: 28292284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
    Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
    Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.